跳至主要内容
临床试验/CTRI/2023/11/059565
CTRI/2023/11/059565尚未招募2 期

A clinical study to evaluate the effect of Bharangyadi Kwatha & Kaliphala Churna in the management of Shwasa Roga w.s.r. to Chronic Obstructive Pulmonary Disease(COPD)

Dr Anjana Mishra1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年11月20日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
A clinical study to evaluate the effect of Bharangyadi Kwatha & Kaliphala churna in the management of Shwasa Roga w.s.r. to Chronic obstructive Pulmonary Disease (COPD)

研究概览

简要总结

I wish to publish my research work after completion of my trial. A total no of 30 patients will be selected from OPD and IPD of Kayachikitsa Department in Rajiv Gandhi Govt Post Graduate Ayurvedic College and hospital Paprola Distt Kangra, H.P. Two groups of 15 patients each will be managed with bharangyadi kwatha and kaliphala churna respectively in the management of Shwasa roga w. s. r. To Chronic obstructive Pulmonary Disease.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Open Label

入排标准

年龄范围
40.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patients having Prolonged expiration with pursed lip breathing, barrel shaped chest, central or peripheral cyanosis, diminished expansion of chest,use of accessory muscles.

排除标准

  • Patients presenting with complications like advanced type 2 respiratory failure, lung collapse and pneumothorax Patients showing more than 12% increment in FEV1/FVC ratio after bronchodilation with 2 puffs of salbutamol 100mcg/puff.

结局指标

主要结局

A clinical study to evaluate the effect of Bharangyadi Kwatha & Kaliphala churna in the management of Shwasa Roga w.s.r. to Chronic obstructive Pulmonary Disease (COPD)

时间窗: 30 days

To compare the effect of Bharangyadi Kwatha and Kaliphala Churna with Doxophylline in the management of Shwasa Roga w.s.r.to Chronic Obstructive Pulmonary Disease (COPD)

时间窗: 30 days

次要结局

  • To assess the clinical safety of Bharangyadi Kwatha & Kaliphala Churna in the management of Shwasa Roga w.s.r to Chronic Obstructive pulmonary Disease (COPD)(30 days)

研究者

发起方
Dr Anjana Mishra
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验